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Key Points
• Human CARD9 deficiency is




Caspase recruitment domain–containing protein 9 (CARD9) is an adaptor molecule in the
cytosol of myeloid cells, required for induction of T-helper cells producing interleukin-17
(Th17 cells) and important in antifungal immunity. In a patient suffering from Candida
dubliniensis meningoencephalitis, mutations in the CARD9 gene were found to result
in the loss of protein expression. Apart from the reduced numbers of CD41 Th17
lymphocytes, we identified a lack of monocyte-derived cytokines in response to Candida
strains. Importantly, CARD9-deficient neutrophils showed a selective Candida albicans
killing defect with abnormal ultrastructural phagolysosomes and outgrowth of hyphae.
The neutrophil killing defect was independent of the generation of reactive oxygen species by the reduced NAD phosphate oxidase
system. Taken together, this demonstrates that human CARD9 deficiency results in selective defect in the host defense against invasive
fungal infection, caused by an impaired phagocyte killing. (Blood. 2013;121(13):2385-2392)
Introduction
Opportunistic invasive fungal infections, such as those with Candida
species, are an increasing problem in medicine, as a consequence,
among other things, of chemotherapy-induced leukopenia.1 The host
defense against Candida infections in human subjects appears to rely
on innate as well as adaptive immune mechanisms.
It has become clear that, in particular, the responses mediated by
the interleukin-17 (IL-17)–producing Th17 subset of T lymphocytes
play an essential role in the host immunity against Candida in-
fections.2 This is illustrated by a variety of genetic defects associated
with the development of T-helper cells producing IL17 (Th17 cells)
in patients and an increased susceptibility to candidiasis.3,4 The role
of IL-17 in the defense against persistent Candida infection has
been directly implicated by the identiﬁcation of IL-17R and IL-17F
mutations in pedigrees suffering from chronic mucocutaneous
candidiasis (CMC).4,5
On the other hand, the innate complement and phagocyte
pathways of host immunity against Candida spp in humans have
been implied in the clearance of these fungal infections. This is
illustrated by the prevalence of invasive Candida spp infections in
chronic granulomatous disease (CGD), which is caused by defects
in the reduced NAD phosphate (NADPH) oxidase enzyme com-
plex needed for microbial killing,6-8 and also by the improved
survival upon granulocyte transfusion in case of disseminated
candidiasis during chemotherapy-related conditions of prolonged
neutropenia.9
Although opsonins such as complement are involved in the
recognition of Candida by phagocytes, there is evidence that the C-
type lectins expressed on the plasma membrane of myeloid cells
interact with b-glucan and mannan residues on the surface of
Candida, and thus play an essential role in recognition as well.10-13
Exactly which relevant effector functions are triggered through
recognition of Candida by lectins, including Dectin-1, Dectin-2,
and other related receptors such as Mincle, is not known. Ex-
perimental evidence from in vitro studies and in vivo studies in mice
suggests that Dectin-1 signals via the tyrosine kinase Syk and via
a downstream complex of the cytosolic proteins caspase recruitment
domain–containing protein 9 (CARD9), Bcl-10, and MALT1 to the
transcription factor nuclear factor-kB, which acts as a central
regulator in the production of inﬂammatory cytokines.11 Of interest,
a recent report has described several cases of CARD9 deﬁciency in
a human family with a history of Candida infections.14 Notably,
there was evidence that some of the patients within this family not
only displayed CMC, but also suffered from invasive Candida
infection in the brain. The same study also showed defects in the
development of Th17 cells in these patients, linking CARD9 to
this pathway of adaptive immunity. However, no studies were
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performed on myeloid cells, which express CARD9 protein most
abundantly.15
Here, we describe a patient with CARD9 deﬁciency who is
suffering from chronic invasive Candida infection of the brain, in
which we show that—apart from reduced Th17 cell activity—the
immune system is more broadly affected. This includes innate




The granulocytes and erythrocytes were separated from the mononuclear
leukocytes and platelets by centrifugation over isotonic Percoll with a speciﬁc
density of 1.076 g/mL. Peripheral blood mononuclear cells (PBMCs) were
cultured in Iscove modiﬁed Dulbecco medium supplemented with a 10% fetal
calf serum, gentamycine, and b-mercaptoethanol. Erythrocytes in the pellet
were lysed. Granulocytes were washed and resuspended in HEPES (N-2-
hydroxyethylpiperazine-N9-2-ethanesulfonic acid)–buffered saline solution.16-18
Immunostaining and FACS analysis
After erythrocyte lysis, expression of surface-bound receptors on granulocytes
was assayed in total leukocyte samples by ﬂow cytometry (ﬂuorescence-
activated cell sorter [FACS]), with commercially available monoclonal anti-
bodies (mAbs), mouse anti-human Dectin-2/CLEC6A (clone 545943),
Dectin-1/CLEC7A (clone 259931) (R&D Systems, Minneapolis, MN),
indirectly labeled with Alexa 488–rabbit-anti-mouse-immunnoglobulin (Ig)
(Molecular Probes, Eugene, OR). Samples were analyzed on an LSRII ﬂow
cytometer equipped with FACSDiva software (BD Biosciences, San Jose,
CA. Cells were gated based on their forward and side scatter, and 10 000
gated events were collected per sample.
Western blot analysis
Analysis of protein expression was performed by western blot.17 The
following antibodies were used for detection: polyclonal rabbit anti-human
CARD9 (Protein Tech Group, Chicago, IL), polyclonal mouse anti-human
CLEC4E/MINCLE (Abcam, Cambridge, United Kingdom), monoclonal
mouse anti-human CLEC6A/Dectin-2, CLEC7A/Dectin-1 (R&D Systems),
and monoclonal mouse anti-human BCL-10 (clone 151; Invitrogen,
Carlsbad, CA).
Lymphocyte activation in vitro
PBMCswere resuspended in phosphate-buffered saline (PBS) at a concentration
of 5 3 106 cells/mL and labeled with 0.5mM 5,6-carboxyﬂuorescein diacetate
succinimidyl ester (Molecular Probes, Eugene, OR) as described previ-
ously.19,20 T-cell proliferative capacity was determined by addition of optimal
concentrations of mAbs against CD3 (CLB-CD3/4.E; IgE isotype) 6 CD28
(CLB-CD28/15E8; IgG1 isotype), or puriﬁed Candida antigen (25 mg/mL).
Cell stimulation and cytokine measurement
For IL-17 induction, PBMCs were cultured at a concentration of 2.5 3 106
T cells per mL and were stimulated for 72 hours with a combination of anti-
CD3 and anti-CD28 mAbs.
Where indicated, PBMCs were restimulated with phorbol myristate
acetate (PMA, 20 ng/mL; Sigma-Aldrich) and ionomycin (1 mg/mL;
Sigma-Aldrich) 6 hours before supernatant collection in the absence or
presence of Brefeldin A.
Cytokine concentrations of IL-17 in culture supernatant were analyzed
with an enzyme-linked immunosorbent assay (ELISA) using anti-human
IL-17A capture mAb (eBioscience; clone eBio64CAP17).
For IL-6 and IL-1b, tumor necrosis factor-a and for IL-8 production,
PBMCs (0.25 3 106 monocytes per mL), NB4 or polymorphonuclear
leukocytes (PMN) (5.0 3 106 cells/mL) were stimulated overnight with the
indicated stimuli. Production of IL-6, IL-1b, tumor necrosis factor-a, and IL-8
was measured in the supernatants with a Pelikine ELISA (Sanquin Reagents,
Amsterdam, The Netherlands) according to the manufacturer’s protocol.
Killing of microorganisms
Short-termmicrobicidal activity of granulocytes was determined as previously
described.21 In brief, Escherichia coli (strain ML-35), Staphylococcus aureus
(strain 502A), andCandida albicans (stably transfected with green ﬂuorescent
protein [GFP]; a generous gift of Dr Alexander Johnson, Department of
Microbiology and Immunology, University of California at San Francisco,
San Francisco, CA) were grown under aerobic conditions at 37°C (bacteria) or
30°C (yeast) overnight in Lysogeny broth (LB). Bacteria and yeasts were then
collected by centrifugation, washed twice in PBS, and resuspended in HEPES
medium. After opsonization (10% [v/v] pooled serum, 15 minutes, at 37°C),
bacteria were added at a ratio of 5:1 neutrophils (4 3 106 cells per mL) and
Candida at ratio of 4:1. At the desired time points, 50-mL samples were diluted
in 2.5 mL of water/NaOH at pH 11.0. At the end of the incubation period, the
number of viable microorganisms in each sample was determined by the
pour-plate method in LB agar. The colony-forming units were counted after an
overnight incubation at 37°C, and the percentage of killing was calculated.21
To assess long-term microbicidal activity of granulocytes, PMNs (5.0 3 106
cells per mL) were cultured overnight with the C albicans–GFP, at a yeast:
neutrophil ratio of 4:1. The appearance of the hyphenated form of C albicans
was assessed with a digital ﬂuorescence microscope (Evos,Westburg, Belgium).
This was also determined after addition of granulocyte–colony-stimulating
factor (G-CSF) (optimal concentration, 20 ng/mL), granulocyte macro-
phage–CSF (optimal concentration, 10 ng/mL), and interferon-g (IFN-g)
(optimal concentration, 100 ng/mL) to the overnight culture of neutrophils
and Candida conidia.
To determine the PMN killing of C albicans hyphae, conidia (OD: 0.2,
625 nm) were cultured in LB for 16 hours at 37°C for formation of a hyphae
monolayer, 100- to 120-mm long and conﬂuence. Neutrophils were added for
2 hours in different effector:target (E:T) ratios, lysed in water (pH 5 11),
washed in PBS, and incubated for 3 hours with yellow tetrazolium salt MTT
(3-(4,5-dimethylthiazol-2-yl)- 2,5-diphenyltetrazolium bromide). The hydro-
genases of the functional hyphae can cleave MTT to its purple derivative
MTT-formazan, which can be dissolved in isopropanol and quantiﬁed by
spectrophotometry. The percentage of viable C albicans hyphae was then
determined.
Electron microscopy analysis of phagolysosomes
Puriﬁed neutrophils were ﬁxed in 2% (w/v) paraformaldehyde with 0.2%
(w/v) glutaraldehyde and then processed for ultrathin cryosectioning.19
Cryosections (50-nm-thick) were cut at 2120°C with diamond knives
(diatome) in a cryo-ultramicrotome (Leica, Vienna, Austria) and transferred
onto carbon/formvar-coated copper grids. The grids were placed on 2% (w/v)
gelatin plates at 37°C, embedded in methylcellulose with 0.6% uranyl
acetate, and examined with a CM10 electron microscope (Philips,
Eindhoven, The Netherlands).22
Statistics
Graphs were drawn and statistical analysis was performed with GraphPad
Prism version 5.00 for Windows (GraphPad Software, San Diego, CA). Data
were evaluated by paired, 2-tailed Student t test and 2-way ANOVA with
post hoc Bonferroni test. The results are presented as the mean 6 SEM, as
indicated. Signiﬁcance is mentioned when P , .05.
Study approval
The study is performed according to Dutch rules and regulations with respect
to the use of human materials from healthy, anonymized volunteers with
written informed consent. All experiments were approved by the Medical
Ethical Committee of Sanquin Research and the Academic Medical Centre in
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Amsterdam which acts according to the Declaration of Helsinki principles
(version Seoul 2008).
Supplemental methods
Supplemental ﬁgures and methods are described in the supplemental data
available on the Blood website.
Results
Case report
We describe an Asian 13-year-old girl who was adopted as an infant.
When she ﬁrst presented at the age of 7 years, she was diagnosed with
Candida dubliniensis meningoencephalitis without any obvious
underlying risk factors for fungal meningitis. Fever, headaches,
behavioral changes, and seizures were the predominant clinical
ﬁndings. CSF analysis revealed an eosinophilic pleocytosis with
increased protein level and decreased CSF glucose. Appropriate
antibiotics were initiated adding antimycotics (amphotericine B,
followed by ﬂuconazole) which resulted in clinical recovery and
normalization of the CSF values. Initial magnetic resonance imaging
showed mainly a deep infarction of the left striatum, meningeal
enhancement, and mild ventricular dilatation. After 6 months of
treatment, the discontinuation resulted in a clinical relapse. Repeated
cultures CSF later disclosed C dubliniensis. Clinical signs and CSF
pleocytosis resolved within several weeks of restarting combined
antifungal therapy (ﬂuconazole, 5-ﬂucytocin). This patient is studied
in more detail (Emmanuel Scalais, in preparation).
CARD9 deficiency and mutation analysis
Surface staining for Dectin-1 and-2 on neutrophils and monocytes,
and western blotting for Dectin-1 and -2,Mincle, and Bcl-10 revealed
normal levels of these proteins in the lysates of the patient’s
neutrophils and monocytes (Figure 1; data not shown). However, the
CARD9 protein appeared absent (Figure 1B), and this was conﬁrmed
with various anti-CARD9 antibodies directed toward different
epitopes of the protein. Sequence analysis revealed that the girl
was compound heterozygote for 2 previously undescribed mutations
c.214G.A and c.1118G.C in CARD9 (supplemental Figure 1A),
resulting in the amino acid substitutions p.Gly72Ser andp.Arg373Pro,
which both comprise highly conserved residues in the CARD9 pro-
tein in vertebrates (supplemental Figure 1B). These mutations were
not found among 100 healthy donors (data not shown). Regarding the
medical family history, the adoption agency was able to contact both
parents. Although they refused collection of DNA for mutation ana-
lysis, clinical data indicated that both parents were over 40 years of
age and healthy to date.
T-cell function and Th17 cells
The presence of AIDS-related invasive Candida infections suggests
a role for CD41 T cells in such fungal infections.23 We tested T-cell
proliferation in response to Candida antigen as well as polyclonal
CD3/CD28 stimulation and detected robust T-cell responses, as was
also true for tetanus toxoid, chickenpox, and herpes simplex virus
antigen (data not shown).
Of the various CD41 T lymphocyte subsets, Th17 cells are
activated by various interleukins and characteristically release IL-17.
This Th17 cell is thought to be a major cell type upon switching from
innate to adaptive immunity.11,24 In our patient, cytokine proﬁles
from T-cell cultures activated by CD3/CD28 showed clear induction
of various cytokines in the supernatant of these cells (data not shown)
but reduced levels of Th17-derived IL-17 (136 6 28 and 770 6 91
pg/mL, patient and controls, respectively; P, .001), consistent with
the data of Glocker et al.14
Monocyte and neutrophil function in CARD9 deficiency
Since CARD9 is primarily expressed in myeloid cells, these cells
were explored further. We ﬁrst investigated the release of in-
ﬂammatory cytokine release by PBMCs and neutrophils in response
to activation by various (un)opsonized pathogens in several inde-
pendent experiments. This showed the virtual absence in Candida-
induced monocytic IL-6 and IL-1b release in the patient PBMCs,
while the response to bacteria (Figure 2A-B) and various Toll-like
receptor (TLR) ligands (data not shown) was not or only partly
affected. To obtain direct evidence that CARD9 was causative for the
defect, we performed lentiviral reconstitution with wild-type CARD9
of hematopoietic stem cells from bone marrow (BM) cultured for 14
days in the presence of macrophage-CSF. The cultured cells were
successfully transduced with CARD9 (80%-90% positive for the
reporter nerve growth factor receptor). Partial reconstitution co-
incided with recovery of BM–derived monocytic cytokines (as
Figure 1. CARD9 deficiency in a patient with systemic candidemia. (A) Surface
expression of (left) Dectin-1 and (right) Dectin-2 in control and patient PMNs and
monocytes was measured by flow cytometry. Dotted lines represent controls and
solid lines patient cells. Isotype controls are shown in gray. Comparable amounts of
dectins were detected on the surface of patient and control cells. (B) Western blot
detection of C-type lectins (Dectin-1, Dectin-2, and Mincle) as well as Bcl-10 and
CARD9 in control and patient neutrophils (indicated as C and P, respectively).
GAPDH was used as a loading control. Results are representative for 3 independent
experiments. GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
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shown for IL-6 upon overnight activation with unopsonized
C albicans) (Figure 2C).
We next measured neutrophil-derived IL-8 production in over-
night cultures. Although there is considerable interexperimental
variation in IL-8 release,16 the response of the patient neutrophils to
C albicans was consistently decreased (Figure 2D), although not as
strongly as the monocyte-derived cytokines. Support for defective
cytokine release by CARD9-deﬁcient neutrophils was obtained from
experiments with myeloid NB4 cells in which CARD9 was efﬁ-
ciently knocked down (supplemental Figure 3A-B).
In the patient neutrophils, we observed no defects in the imme-
diate induction of NADPH oxidase activity by the various stimuli
tested—either primed with platelet-activating factor (PAF) or TLR
ligands for subsequent fMLP-induced NADPH oxidase activity, or
directly activated by fMLP or the phorbol ester PMA. The same was
true for induction of the respiratory burst by the yeast-derived particle
zymosan, C albicans particles, or aggregated IgG (Figure 3). These
ﬁndings indicate that the patient cells had a completely normal ca-
pacity to generate reactive oxygen species (ROS) and normal reco-
gnition and signaling for these immediate responses.17,25 Adhesion
and chemotaxis upon activation by TLR ligands or chemoattractants
such as complement fragment C5a, PAF, or the chemokine IL-8,
were all normal (not shown).
Figure 2. Cytokine production by CARD9-deficient leukocytes and by the
patient’s CD341 hematopoietic stem cells following CARD9 transduction.
Leukocytes from the patient and a control subject were incubated overnight with the
indicated stimuli. Culture supernatants were collected and the concentrations of IL-6
and IL-1b by (A-B) PBMCs or (D) IL-8 by neutrophils were assessed by ELISA. To
examine the effect of mutated CARD9 on cytokine production, a human wild-type
CARD9 complementary DNA (cDNA) was cloned into a lentiviral expression vector.
(C) Following transduction, macrophage-CSF–cultured BM-derived monocytic cells
of the patient and healthy controls were stimulated with C albicans or S aureus, and
the production of IL-6 was assessed by ELISA. Results represent 2 experiments in
triplicate from different BM aspirates of the patient and from healthy controls. Results
are means 6 SEM of measurement from 4 to 6 independent experiments; *P , .01;
**P , .001.
Figure 3. NADPH oxidase activity and phagocytosis of DHR-labeled C albicans
in CARD9-deficient neutrophils. (A) To assess the effect of CARD9 deficiency on
production of ROS, patient and control neutrophils were stimulated with various
stimuli: zymosan, STZ, PMA, PAF followed by fMLP, Candida particles (ratio with
neutrophils, 1:4) and heat-aggregated Ig, in the presence of Amplex Red and
horseradish peroxidase. Means 6 SEM of at least 3 different experiments. (B) The
phagocytosis of DHR-labeled C albicans by the CARD9-deficient and control
neutrophils was determined by flow cytometry. Results represent data from 2
different experiments. fMLP, formyl-Met-Leu-Phe; STZ, serum-treated zymosan.
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When neutrophil killing capacity was studied, the immediate
killing response, within 1-2 hours, by CARD9-deﬁcient cells was
signiﬁcantly impaired with unopsonized C albicans conidia and
normal with serum-opsonized conidia (Figure 4A). In contrast, the
killing of opsonized gram-positive S aureus or opsonized gram-
negative E coli was not different from control neutrophil killing
(supplemental Figure 4A). We investigated the cytotoxic response
to C albicans. Even though the patient was infected with the
philogenetically closely related dubliniensis strain, it has been
described that neutrophils have a similar cytotoxic response toward
C albicans similar to C dubliniensis in terms of phagocytosis,
oxidative burst, and killing.26
Importantly, when Candida killing after 18-24 hours incubation
was evaluated with CARD9-deﬁcient neutrophils and opsonized C
albicans conidia, a clear outgrowth of hyphae was observed which
was even more striking with unopsonized C albicans (Figure 4B-
C, supplemental Figure 5, supplemental Movies 1-4). In contrast
to CARD9-dependent killing, such Candida outgrowth was not
observed after overnight incubation of neutrophils from CGD
patients with unopsonized C albicans (Figure 4B-C). These data
demonstrate that a nonoxidative CARD9-dependent and non-
redundant mechanism in neutrophils prevents outgrowth of
unopsonized Candida. There is a deﬁnite role of ROS in Candida
killing, but predominantly with the opsonized C albicans conidia.
Under these conditions, CGD neutrophils fail to prevent conidia
from hyphenation. Of note, CARD9-deﬁcient neutrophils appeared
to kill preformed unopsonized C albicans hyphae with similar
efﬁciency as control neutrophils (Figure 4D), indicating that
the process of hyphenation itself is insufﬁciently controlled by
CARD9-deﬁcient neutrophils while uptake is intact (supplemental
Figure 4B).
Furthermore, measuring the oxidation of dihydrorhodamine
(DHR) following the phagocytosis of labeled Candida conidia by
neutrophils revealed that patient and control cells showed identical
responses (Figure 3B). The normal DHR response means that in
the complex process of uptake degranulation and NADPH oxidase
activity gets normally activated upon phagolysosome formation.
Only after degranulation of the myeloperoxidase from azurophilic
granules together with the NAPDH oxidase–derived ROS generation
will a DHR signal be generated. Finally, addition of activating factors
G-CSF, granulocyte macrophage–CSF, or IFN-g, which are known
to enhance neutrophil function and survival,27 was without any effect
on outgrowth of Candida hyphae (not shown).
Because of the normal ROS generation in the patient’s neutrophils
upon activation by yeast particles, the possibility that the lysosomal
killing was dysfunctional was further investigated by ultrastructural
analysis. Although neither the release of the content of azurophilic
or speciﬁc granules nor the NADPH oxidase activity in these
Figure 4. Killing of C albicans by CARD9-deficient neutrophils. (A) Killing
efficacy of patient and control neutrophils of unopsonized and opsonized C albicans
conidia was assessed by standard colony-forming unit assay. Patient and control
neutrophils were incubated with C albicans conidia for 2 hours, and the colonies were
counted after overnight incubation of the remaining Candida conidia. Results are
Figure 4 (continued) means 6 SEM of at least 3 different assays; *P , .05. (B)
Neutrophils from healthy controls, from the CARD9-deficient patient and from CGD
patients (n 5 9), were cocultured overnight with C albicans–GFP and assessed
microscopically. Massive outgrowth of the hyphenated form of C albicans–GFP was
observed, when cocultured overnight with CARD9-deficient cells. Bright-green
fluorescence of hyphae indicates viable Candida. Such outgrowth was not detected
when C albicans was cocultured with control neutrophils. (C) Clusters of hyphae
were quantified after overnight incubation of 1 3 105 neutrophils with different
numbers of Candida conidia. Data are representative for at least 3 experiments.
Original magnification, 320; scale bar, 200 mm. (D) The capacity of patient and
control neutrophils to kill Candida hyphae was determined by MTT assay.
Neutrophils in different concentrations were incubated with monolayer of Candida
hyphae for 2 hours. The viability of hyphae was assessed by the MTT assay. Results
are means 6 SEM of at least 3 different assays.
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CARD9-deﬁcient neutrophils was found to be different from control
neutrophils (Figure 3A, supplemental Figure 4C), the phagolyso-
somes in the patient cells following unopsonized Candida albicans,
but not S aureus, uptake were abnormal, as clearly demonstrated by
electron microscopy (EM) (Figure 5). Taking all these data together,
a hitherto unidentiﬁed, nonredundant, and relatively selective killing
mechanism in neutrophils for fungal organisms is implicated, which
depends on the normal function of CARD9.
Discussion
S aureus and Candida species are the second and third leading
causes of bloodstream infections in hospitalized patients.28 These
organisms jointly cause at least 150 000 clinical bloodstream in-
fections resulting in very large health care expenditures and ;40 000
deaths per year in the United States and Europe each.29-31
Identiﬁcation of immune mechanisms of protective adaptive im-
munity against these organisms is critical to lay the groundwork for
development of active preventive and therapeutic strategies against
these microorganisms. The induction of cell-mediated immunity to C
albicans is one of the main tasks of cells of the innate immune
system, and in vitro evidence suggests that integrin aMb2 (CR3,
Mac-1, CD11b/CD18) is the principal leukocyte receptor involved
in recognition of the fungus.18
Although T cells are important in antifungal defense, T-cell
reactivity seems to be particularly important for epithelial defense
against molds. Among the various subsets of IL-17–producing cells,
memory CD41 Th17 cells have received most attention regarding
their participation in antifungal immune reactivity.2 Apart from the
release of G-CSF and chemokines to activate neutrophils for
microbial clearance, IL-17 also directly induces epithelial cells to
produce microbial peptides against, for instance, S aureus and
Candida species.32 Glocker et al14 studied a family with homozygous
CARD9 mutation and conﬁrmed the defective Th17 response. In
addition, we demonstrate that in human PBMCs the production of
IL-6 and IL-1b in response to C albicans is dependent on CARD9.
Hereby, we were able to conﬁrm these ﬁndings, as described in the
card9-knockout mice by LeibundGut-Landmann et al.33 The
decrease in Staphylococcus-triggered IL-1b in monocytes may
suggest a role for CARD9 in this pathway. Indeed, there is evidence
that CARD9 signals facilitate the TLR andNod2 pathways to activate
mitogen-activated protein kinase and tyrosine kinase pathways to
activate nuclear factor-kB for cytokine production.34
We now show that the neutrophils in CARD9 deﬁciency have
a selective defect in Candida killing. Although monocytes and/or
dendritic cells may fail to induce Th17 responses in CARD9
deﬁciency because they do not produce pivotal cytokines such as
IL-1b for Th17 differentiation, the killing defect in neutrophils may
directly contribute to the invasive nature of the fungal manifes-
tations in CARD9 deﬁciency and thus contrasts with the Th17-
associated noninvasive, more localized yeast infections in CMC.
The exact mechanism by which CARD9-defective neutrophils fail
to eliminate Candida molds remains to be identiﬁed. Some important
observations about a potential working mechanism have been ob-
tained. First, the NADPH oxidase activity and, second, the degran-
ulation of azurophilic and speciﬁc granules in the patient’s neutrophils
are normal upon activation (Figure 3, supplemental Figure 4C).
This was further supported by the normal oxidative response over
time when DHR-labeled Candida conidia were taken up by CARD9-
deﬁcient neutrophils. In turn, CGD neutrophils which are unable
to produce superoxide for oxidative killing were unaffected in
their killing activity under conditions where massive Candida conidia
outgrowth and hyphenation was observed in the case of CARD9
deﬁciency. The CARD9-mediated killing mechanism differs from
the opsonin-mediated killing pathway, which seems to be complet-
ely dependent on fully functional NAPDH oxidase activity as il-
lustrated by the results with neutrophils from CGD patients. These
ﬁndings are clearly in contrast with a study on BM-derived mac-
rophages from card9-knockout mice, showing less ROS in response
to C albicans.35
Moreover, the CR3 expression and integrin activity were
considered to be normal in all adhesion and chemotaxis assays, as
well as in the uptake of zymosan or Candida particles. The ex vivo
immediate, early killing response of unopsonized Candida conidia
was impaired, but it could be restored upon opsonization with human
serum. This indicates that yeast b-glucan pattern recognition recep-
tors, such as Dectin-1 and/or CR3, depend on CARD9 to activate a
selective (nonoxidative) cytotoxic mechanism. This notion is sup-
ported by the normal killing of hyphae, which are known to shield
their b-glucans, and are instead recognized by mannan-speciﬁc
receptors, such as TLR-2, TLR-4, CR3, and Dectin-2.36,37
Still, the ultimate Candida evasion from the patient’s cells in
a prolonged, late killing assay indicates that the rapid and complete
elimination of Candida is inadequate and results in escape of
Figure 5. Phagolysosome formation upon uptake of C albicans by human
neutrophils. (A) CARD9-deficient and control neutrophils were cocultured overnight
with unopsonized C albicans. Ultrastructural analysis was performed by EM. EM
pictures showed bulging phagolysosome formation upon uptake of C albicans in the
patient neutrophils in contrast to the control neutrophils, obtained in 3 independent
experiments. (B) The ratio of Candida conidia diameter to the phagosomal space
diameter is significantly reduced in CARD9-deficient neutrophils, taking into con-
sideration that the diameter of the Candida conidia was significantly increased in the
case of CARD9 deficiency compared with the control (1.36 0.2 mm vs 0.86 0.1 mm;
P , .05). Moreover, the phagosomes of CARD9-deficient neutrophils contained
more Candida conidia than the control neutrophils (1.5 6 0.1 vs 1.1 6 0.1 conidia/
phagosome, P , .05). Taken together, the phagosomes of the CARD9-deficient
patient have a strongly enlarged appearance. Results are means 6 SEM of
measurement from 3 independent experiments; **P , .001.
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viable yeast after uptake, resulting in the outgrowth of hyphae. Early
after activation of uptake and the intracellular killing reaction, these
phagolysosomes tend to swell because the osmotic pressure increases
during the breakdown of microbial proteins.37 The key machinery
required for the export of such osmotically active phagolysosomal
breakdown products is unknown, but a role for CARD9 in this
process may explain the ultrastructural ﬁndings. Alternative expla-
nations may be linked to the dysregulation of autophagy, since
CARD9 has been found to associate with Rubicon, a protein known
to inhibit autophagosome maturation.38 Autophagosomes have been
morphologically deﬁned by a quintessential feature: that is, the
presence of “double membrane vesicles” as the most critical hallmark
of this cellular process.39 We assessed this phenomenon by analyzing
EM pictures taken at 2 hours, 4 hours, and after overnight co-
incubation of neutrophils and Candida strains. In none of the EM
pictures, neither in the patient nor in control neutrophils, was the
characteristic autophagy signature of double membranes observed
(data not shown). In the absence of CARD9, uninhibited Rubicon
activity would lead to increased autophagy which seems apparently
not to be the case in the patient’s neutrophils.
The intact killing response to bacterial strains by CARD9-
deﬁcient neutrophils indicates that a distinct and nonredundant killing
mechanism is induced by the yeast species tested and strictly depends
on CARD9 in human neutrophils. In addition, we have studied the
inhibition of Aspergillus fumigatus germination. CARD9-deﬁcient
neutrophils normally inhibited the germination of A fumigatus (data
not shown). This ﬁnding suggests that the neutrophil killing defect
is speciﬁc for Candida species and this is consistent with the
susceptibility to Candida infections observed in our patient and those
previously reported.14
Our ﬁndings show that the defect inCandida killing by neutrophils
was particularly pronounced in the absence of serum, and this might
indeed be relevant in the context of the invasive brain infections
observed in our patient and in the patients previously described.14 The
central nervous system parenchyma is separated from the circulation
by the blood-brain-barrier, which limits the access of plasma proteins,
including immunoglobulins and complement.40 Therefore, in addition
to the other potential pathophysiological mechanisms, the central
nervous system could be particularly sensitive toCandida infections in
the case of CARD9 deﬁciency. The lack of inﬂammatory cytokines
and neutrophil chemoattractants produced by monocytes and dendritic
cells, and possibly also macrophage-like microglia cells, will
exaggerate the defect in fungal clearance. The antifungal role of
neutrophils is known from clinical experience with intensive cancer
treatment.9 Our data suggest that hematopoietic stem cell trans-
plantation is the only deﬁnite option for curation of CARD9
deﬁciency.
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